Marked hyperglycemia attenuates anesthetic preconditioning in human-induced pluripotent stem cell-derived cardiomyocytes

Anesthesiology

Volumn 117, Issue 4, 2012, Pages 735-744

  Canfield, Scott G ^a   Sepac, Ana ^a   Sedlic, Filip ^a   Muravyeva, Maria Y ^a   Bai, Xiaowen ^a   Bosnjak, Zeljko J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; ENHANCED GREEN FLUORESCENT PROTEIN; GLUCOSE; ISOFLURANE; LACTATE DEHYDROGENASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; TROPONIN T;

ANESTHESIA; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL MEMBRANE DEPOLARIZATION; CELL PROTECTION; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETIC PATIENT; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PLURIPOTENT STEM CELL; PRIORITY JOURNAL;

ANESTHETICS; ANESTHETICS, INHALATION; CARDIAC MYOSINS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 2; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VECTORS; HUMANS; HYPERGLYCEMIA; ISOFLURANE; L-LACTATE DEHYDROGENASE; LENTIVIRUS; MEMBRANE POTENTIALS; MICRODISSECTION; MICROSCOPY, CONFOCAL; MITOCHONDRIAL MEMBRANES; MYOCYTES, CARDIAC; MYOSIN LIGHT CHAINS; PERMEABILITY; PLURIPOTENT STEM CELLS;

EID: 84866734703     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3182655e96     Document Type: Article

References (43)

1. Solomon CG: Reducing cardiovascular risk in type 2 diabetes. N Engl J Med 2003; 348:457-9 (Pubitemid 36159365)
2. Stadnicka A, Marinovic J, Bienengraeber M, Bosnjak ZJ: Impact of in vivo preconditioning by isoflurane on adenosine triphosphate-sensitive potassium channels in the rat heart: Lasting modulation of nucleotide sensitivity during early memory period. ANESTHESIOLOGY 2006; 104:503-10
3. Ljubkovic M, Mio Y, Marinovic J, Stadnicka A, Warltier DC, Bosnjak ZJ, Bienengraeber M: Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am J Physiol Cell Physiol 2007; 292:C1583-90 (Pubitemid 47082397)
4. Kersten JR, Schmeling TJ, Pagel PS, Gross GJ, Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70 (Pubitemid 27435379)
5. Tanaka K, Kehl F, Gu W, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Isoflurane-induced preconditioning is attenuated by diabetes. Am J Physiol Heart Circ Physiol 2002; 282:H2018-23 (Pubitemid 34663008)
6. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. ANESTHESIOLOGY 2002; 96:183-8 (Pubitemid 34032499)
7. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA: Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-20
8. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ: Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009; 104:e30-41
9. Zwi L, Caspi O, Arbel G, Huber I, Gepstein A, Park IH, Gepstein L: Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 2009; 120:1513-23
10. Sepac A, Sedlic F, Si-Tayeb K, Lough J, Duncan SA, Bienengraeber M, Park F, Kim J, Bosnjak ZJ: Isoflurane preconditioning elicits competent endogenous mechanisms of protection from oxidative stress in cardiomyocytes derived from human embryonic stem cells. ANESTHESIOLOGY 2010; 113: 906-16
11. Huber I, Itzhaki I, Caspi O, Arbel G, Tzukerman M, Gepstein A, Habib M, Yankelson L, Kehat I, Gepstein L: Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. Faseb J 2007; 21:2551-63 (Pubitemid 47230684)
12. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ: Disease- specific induced pluripotent stem cells. Cell 2008; 134: 877-86
13. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA: Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51:297-305
14. Henderson SA, Spencer M, Sen A, Kumar C, Siddiqui MA, Chien KR: Structure, organization, and expression of the rat cardiac myosin light chain-2 gene. Identification of a 250- base pair fragment which confers cardiac-specific expression. J Biol Chem 1989; 264:18142-8 (Pubitemid 19279285)
15. Zhu H, Garcia AV, Ross RS, Evans SM, Chien KR: A conserved 28-base-pair element (HF-1) in the rat cardiac myosin lightchain- 2 gene confers cardiac-specific and alpha-adrenergicinducible expression in cultured neonatal rat myocardial cells. Mol Cell Biol 1991; 11:2273-81 (Pubitemid 21895600)
16. Caspi O, Itzhaki I, Kehat I, Gepstein A, Arbel G, Huber I, Satin J, Gepstein L: In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev 2009; 18:161-72
17. Park F, Sweeney WE, Jia G, Roman RJ, Avner ED: 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. J Am Soc Nephrol 2008; 19:1929-39
18. Park F: Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice. Hum Gene Ther 2003; 14:1489-94 (Pubitemid 37268226)
19. Pravdic D, Sedlic F, Mio Y, Vladic N, Bienengraeber M, Bosnjak ZJ: Anesthetic-induced preconditioning delays opening of mitochondrial permeability transition pore via protein Kinase C-epsilon-mediated pathway. ANESTHESIOLOGY 2009; 111:267-74
20. Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ: Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 2000; 192:1001-14
21. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ: Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 2004; 113:1535-49 (Pubitemid 39071677)
22. Hüser J, Rechenmacher CE, Blatter LA: Imaging the permeability pore transition in single mitochondria. Biophys J 1998; 74:2129-37 (Pubitemid 28157948)
23. Hüser J, Blatter LA: Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem J 1999; 343 Pt 2:311-7 (Pubitemid 29511762)
24. 2-. Am J Physiol Cell Physiol 2010; 299:C506-15
25. Sedlic F, Pravdic D, Ljubkovic M, Marinovic J, Stadnicka A, Bosnjak ZJ: Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane. Anesth Analg 2009; 109:405-11
26. Hanley PJ, Ray J, Brandt U, Daut J: Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria. J Physiol 2002; 544:687-93 (Pubitemid 35355950)
27. Mio Y, Bienengraeber MW, Marinovic J, Gutterman DD, Rakic M, Bosnjak ZJ, Stadnicka A: Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: Roles for mitochondrial respiration and sarcolemmal adenosine triphosphatesensitive potassium channel activity. ANESTHESIOLOGY 2008; 108: 612-20 (Pubitemid 351440581)
28. Lough J, Sugi Y: Endoderm and heart development. Dev Dyn 2000; 217:327-42 (Pubitemid 30185557)
29. Postic C, Mauvais-Jarvis F, Girard J: Mouse models of insulin resistance and type 2 diabetes. Ann Endocrinol (Paris) 2004; 65:51-9 (Pubitemid 38590702)
30. Collins FS: Reengineering translational science: The time is right. Sci Transl Med 2011; 3:90cm17
31. Inoue H, Yamanaka S: The use of induced pluripotent stem cells in drug development. Clin Pharmacol Ther 2011; 89: 655-61
32. Laustriat D, Gide J, Peschanski M: Human pluripotent stem cells in drug discovery and predictive toxicology. Biochem Soc Trans 2010; 38:1051-7
33. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, Dorn T, Goedel A, Höhnke C, Hofmann F, Seyfarth M, Sinnecker D, Schömig A, Laugwitz KL: Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010; 363:1397-409
34. Marchetto MC, Brennand KJ, Boyer LF, Gage FH: Induced pluripotent stem cells (iPSCs) and neurological disease modeling: Progress and promises. Hum Mol Genet 2011; 20:R109-15
35. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321:1218-21
36. Marinovic J, Bosnjak ZJ, Stadnicka A: Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. ANESTHESIOLOGY 2006; 105:98-104 (Pubitemid 44305197)
37. Ghosh S, Standen NB, Galinianes M: Failure to precondition pathological human myocardium. J Am Coll Cardiol 2001; 37:711-8 (Pubitemid 32202434)
38. Kersten JR, Montgomery MW, Ghassemi T, Gross ER, Toller WG, Pagel PS, Warltier DC: Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol 2001; 280:H1744-50
39. Murphy E, Steenbergen C: Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 2008; 88:581-609 (Pubitemid 351520088)
40. Davidson SM, Hausenloy D, Duchen MR, Yellon DM: Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int J Biochem Cell Biol 2006; 38:414-9 (Pubitemid 41821888)
41. Crompton M: The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341 Pt 2:233-49 (Pubitemid 29373645)
42. Novalija E, Varadarajan SG, Camara AK, An J, Chen Q, Riess ML, Hogg N, Stowe DF: Anesthetic preconditioning: Triggering role of reactive oxygen and nitrogen species in isolated hearts. Am J Physiol Heart Circ Physiol 2002; 283:H44-52 (Pubitemid 34705322)
43. Lango R, Mroziński P: Clinical importance of anaesthetic preconditioning. Anestezjol Intens Ter 2010; 42:206-12